Kraig Biocraft Laboratories, Inc. KBLB
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.52% | -19.69% | 47.83% | -107.91% | -21.02% |
| Total Depreciation and Amortization | 680.65% | -75.00% | 15.35% | 270.69% | 1.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.91% | 9,672.73% | -99.75% | 2,361.97% | 160.27% |
| Change in Net Operating Assets | -28.26% | -38.37% | 104.47% | -37.03% | 10.52% |
| Cash from Operations | -13.03% | -17.84% | 2.68% | -4.24% | -1.98% |
| Capital Expenditure | -102.84% | -781.25% | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -67.06% | 51.36% | -- |
| Cash from Investing | -102.84% | -119.64% | -67.77% | 55.26% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -50.00% | -- | -- |
| Issuance of Common Stock | -31.41% | 142.85% | -36.67% | 55.40% | 309.10% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -31.41% | 173.10% | -40.92% | 48.13% | 334.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -54.51% | 390.33% | -71.23% | 100.82% | 240.61% |